Heart Failure and Transplantation with Dr Ileana Piña http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina Dr Ileana Piña, cardiologist and heart failure and transplantation specialist, shares her views on cardiology news and events. Cardiologist and heart failure and transplantation specialist, Dr Ileana Piña, from Albert Einstein College of Medicine at the Montefiore Medical Center shares her views on cardiology news and events en-us theheart.org theheart.org info@theheart.org http://blogs.theheart.org/images/pina-on-cardiology/rss_banner_url.jpg Cardiologist and heart failure and transplantation specialist, Dr Ileana Piña, from Albert Einstein College of Medicine at the Montefiore Medical Center shares her views on cardiology news and events http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina HF update from ACC: Tackling readmission rates, galectin-3; chronic lung disease comorbidity Heart failure and transplantation with Dr Ileana Piña info@theheart.org From the convention floor at ACC 2012, Dr Ileana Piña shares her picks of the most important developments in heart failure.<img src="http://feeds.feedburner.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~4/tUA9cvRVnRU" height="1" width="1"/> From the convention floor at ACC 2012, Dr Ileana Piña shares her picks of the most important developments in heart failure.

See also:

]]> Mon, 26 Mar 2012 09:50:00 -0400 http://feedproxy.google.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~3/tUA9cvRVnRU/hf-update-from-acc-tackling-readmission-rates-galectin3-chronic-lung-disease-comorbidity http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2012/3/26/hf-update-from-acc-tackling-readmission-rates-galectin3-chronic-lung-disease-comorbidity http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2012/3/26/hf-update-from-acc-tackling-readmission-rates-galectin3-chronic-lung-disease-comorbidity#comments Heart failure and transplantation with Dr Ileana Piña http://blogs.theheart.org/images/thumbnails/hf-update-from-acc-tackling-readmission-rates-galectin3-chronic-lung-disease-comorbidity.jpg 1 acc 2012 acc 2012 http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2012/3/26/hf-update-from-acc-tackling-readmission-rates-galectin3-chronic-lung-disease-comorbidity LVADs: From A to Z with Dr James Kirklin Heart failure and transplantation with Dr Ileana Piña info@theheart.org Dr Ileana Piña catches up with Dr James Kirklin for a comprehensive discussion of left ventricular assist devices. Find out more about eligibility, new devices, how to treat pulseless patients, INTERMACS, rates of infection with LVADs, and cost.<img src="http://feeds.feedburner.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~4/ZJ2lYdjZQTw" height="1" width="1"/> Dr Ileana Piña catches up with Dr James Kirklin for a comprehensive discussion of left ventricular assist devices. Find out more about eligibility, new devices, how to treat pulseless patients, INTERMACS, rates of infection with LVADs, and cost.

 

See also:

Biggest cardiology stories of 2011

Pumped about LVADs: Many eligible HF patients would "definitely" consider one

HeartMate II performs well in "real world"

 

Rose EA, Gelijns AC, Moskowitz AJ, et al, for the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001; 345:1435-1443. Available here.

]]> Wed, 25 Jan 2012 09:15:00 -0500 http://feedproxy.google.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~3/ZJ2lYdjZQTw/lvads-from-a-to-z-with-dr-james-kirklin http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2012/1/17/lvads-from-a-to-z-with-dr-james-kirklin http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2012/1/17/lvads-from-a-to-z-with-dr-james-kirklin#comments Heart failure and transplantation with Dr Ileana Piña http://blogs.theheart.org/images/thumbnails/lvads-from-a-to-z-with-dr-james-kirklin.jpg 0 aha 2011 aha 2011 http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2012/1/17/lvads-from-a-to-z-with-dr-james-kirklin Digoxin toxicity in heart-failure patients with Dr Paul Hauptman Heart failure and transplantation with Dr Ileana Piña info@theheart.org Although not as commonly prescribed as it once was, digoxin is still a common fifth-line agent for heart-failure patients. Drs Ileana Piña and Paul Hauptman discuss a case of digoxin toxicity and how to recognize, treat, and avoid it.<img src="http://feeds.feedburner.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~4/Tx-9PA52Zg8" height="1" width="1"/> Although not as frequently prescribed as it once was, digoxin is still a common fifth-line agent for heart-failure patients. Drs Ileana Piña and Paul Hauptman discuss a case of digoxin toxicity and how to recognize, treat, and avoid it.

See also:

Hussain Z, Swindle J, Hauptman PJ. Digoxin use and digoxin toxicity in the post-DIG trial era. J Card Fail 2006; 12:343-346. Abstract.

Conen D, Chae CU, Glynn RJ, et al. Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. JAMA 2011; 305:2080-2087. Abstract.

Rathore SS, Wang Y, Krumholz HM. Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med 2002; 347:1403-1411. Abstract.

Adams KF Jr, Patterson JH, Gattis WA, et al. Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis. J Am Coll Cardiol 2005; 46:497-504. Abstract.

Withering W. An account of the foxglove and some of its medical uses with practical remarks on dropsy and other diseases. In: Willins FA, Keys TE, eds. Classics of Cardiology. New York: Henry Schyuman, Dover Publications, 1941:231-252. 

Focus on atrial fibrillation with Dr Bruce Wilkoff

]]> Fri, 06 Jan 2012 13:00:00 -0500 http://feedproxy.google.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~3/Tx-9PA52Zg8/digoxin-toxicity-in-heartfailure-patients-with-dr-paul-hauptman http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2012/1/6/digoxin-toxicity-in-heartfailure-patients-with-dr-paul-hauptman http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2012/1/6/digoxin-toxicity-in-heartfailure-patients-with-dr-paul-hauptman#comments Heart failure and transplantation with Dr Ileana Piña http://blogs.theheart.org/images/thumbnails/digoxin-toxicity-in-heartfailure-patients-with-dr-paul-hauptman.jpg 2 aha 2011 aha 2011 http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2012/1/6/digoxin-toxicity-in-heartfailure-patients-with-dr-paul-hauptman The "ICD conversation": When to implant, when to consider turning it off Heart failure and transplantation with Dr Ileana Piña info@theheart.org It's essential to hold a frank discussion to inform potential candidates of the advantages and disadvantages of having an ICD placed and to counsel end-of-life patients about when it may be appropriate to turn it off.<img src="http://feeds.feedburner.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~4/kCIEVDaUyUM" height="1" width="1"/> It's essential to hold a frank discussion to inform potential candidates of the advantages and disadvantages of having an ICD placed and to counsel end-of-life patients about when it may be appropriate to turn it off.

]]> Tue, 06 Dec 2011 15:05:00 -0500 http://feedproxy.google.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~3/kCIEVDaUyUM/the-icd-conversation-when-to-implant-when-to-consider-turning-it-off http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2011/12/6/the-icd-conversation-when-to-implant-when-to-consider-turning-it-off http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2011/12/6/the-icd-conversation-when-to-implant-when-to-consider-turning-it-off#comments Heart failure and transplantation with Dr Ileana Piña http://blogs.theheart.org/images/thumbnails/the-icd-conversation-when-to-implant-when-to-consider-turning-it-off.jpg 1 http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2011/12/6/the-icd-conversation-when-to-implant-when-to-consider-turning-it-off Focus on heart failure at TCT 2011 Heart failure and transplantation with Dr Ileana Piña info@theheart.org The new guidelines for PCI and CABG have provided the backdrop for a stimulating meeting which is overflowing with fascinating sessions, including a review of devices for heart failure.<img src="http://feeds.feedburner.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~4/0I1gaNOA0tM" height="1" width="1"/> The new guidelines for PCI and CABG have provided the backdrop for a stimulating meeting, which is overflowing with fascinating sessions, including a review of devices for heart failure.

See also:

New PCI, CABG guidelines emphasize team approach

Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2011; DOI: 10.1016/j.jacc.2011.08.009. Available at: http://content.onlinejacc.org.

Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 2011; DOI:10.1016/j.jacc.2011.08.007. Available at: http://content.onlinejacc.org.

]]> Thu, 10 Nov 2011 15:25:00 -0500 http://feedproxy.google.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~3/0I1gaNOA0tM/focus-on-heart-failure-at-tct-2011 http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2011/11/10/focus-on-heart-failure-at-tct-2011 http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2011/11/10/focus-on-heart-failure-at-tct-2011#comments Heart failure and transplantation with Dr Ileana Piña http://blogs.theheart.org/images/thumbnails/focus-on-heart-failure-at-tct-2011.jpg 0 TCT 2011 TCT 2011 http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2011/11/10/focus-on-heart-failure-at-tct-2011 Certification in advanced HF and transplant cardiology Heart failure and transplantation with Dr Ileana Piña info@theheart.org Thanks to the collaboration of the HFSA and the American Board of Internal Medicine (ABIM), certification now exists for cardiologists specializing in advanced heart failure, transplant, and mechanical assist devices. Find out more.<img src="http://feeds.feedburner.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~4/wzFqXTB6vss" height="1" width="1"/> Thanks to the collaboration of the HFSA and the American Board of Internal Medicine (ABIM), certification now exists for cardiologists specializing in advanced heart failure, transplant, and mechanical assist devices. Find out more about the new subspecialty and the drive to promote a lifetime of learning.

See also:

ABIM Certification in Advanced Heart Failure and Transplant Cardiology

]]> Mon, 07 Nov 2011 09:30:00 -0500 http://feedproxy.google.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~3/wzFqXTB6vss/certification-in-advanced-hf-and-transplant-cardiology http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2011/11/7/certification-in-advanced-hf-and-transplant-cardiology http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2011/11/7/certification-in-advanced-hf-and-transplant-cardiology#comments Heart failure and transplantation with Dr Ileana Piña http://blogs.theheart.org/images/thumbnails/certification-in-advanced-hf-and-transplant-cardiology.jpg 1 HFSA 2011 HFSA 2011 http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2011/11/7/certification-in-advanced-hf-and-transplant-cardiology Focus on atrial fibrillation with Dr Bruce Wilkoff Heart failure and transplantation with Dr Ileana Piña info@theheart.org Focus on atrial fibrillation with Dr Bruce Wilkoff and Dr Ileana Pina<img src="http://feeds.feedburner.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~4/Iijy33Lf2MY" height="1" width="1"/> Atrial fibrillation is prevalent in 9% of the population over 80 years of age and is a growing health concern. Dr Ileana Piña sits down with Dr Bruce Wilkoff, president of the Heart Rhythm Society, for an overview of recent research.

]]> Thu, 20 Oct 2011 14:15:00 -0400 http://feedproxy.google.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~3/Iijy33Lf2MY/focus-on-atrial-fibrillation-with-dr-bruce-wilkoff http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2011/10/20/focus-on-atrial-fibrillation-with-dr-bruce-wilkoff http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2011/10/20/focus-on-atrial-fibrillation-with-dr-bruce-wilkoff#comments Heart failure and transplantation with Dr Ileana Piña http://blogs.theheart.org/images/thumbnails/focus-on-atrial-fibrillation-with-dr-bruce-wilkoff.jpg 2 http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2011/10/20/focus-on-atrial-fibrillation-with-dr-bruce-wilkoff Optimizing medical management with biomarker-guided care Heart failure and transplantation with Dr Ileana Piña info@theheart.org What role can biomarkers play in reducing bad clinical outcomes such as rehospitalization? Dr Piña caught up with Dr Jim Januzzi during ESC Congress 2011 to discuss his latest research and how it may affect care for patients with heart failure.<img src="http://feeds.feedburner.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~4/13rhavx6BBo" height="1" width="1"/> What role can biomarkers play in reducing poor clinical outcomes such as rehospitalization? Dr Ileana Piña caught up with Dr Jim Januzzi during ESC Congress 2011 to discuss his latest research and how it may improve care for patients with heart failure.

]]> Mon, 19 Sep 2011 11:40:00 -0400 http://feedproxy.google.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~3/13rhavx6BBo/optimizing-medical-management-with-biomarkerguided-care http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2011/9/16/optimizing-medical-management-with-biomarkerguided-care http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2011/9/16/optimizing-medical-management-with-biomarkerguided-care#comments Heart failure and transplantation with Dr Ileana Piña http://blogs.theheart.org/images/thumbnails/optimizing-medical-management-with-biomarkerguided-care.jpg 1 ESC 2011 ESC 2011 http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2011/9/16/optimizing-medical-management-with-biomarkerguided-care Women with atrial fibrillation: Focus on etiology and treatment Heart failure and transplantation with Dr Ileana Piña info@theheart.org An important observational study published in JAMA tracked over 34 000 women for more than 15 years and showed that cardiovascular mortality was significantly higher for women who developed atrial fibrillation as an incident event.<img src="http://feeds.feedburner.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~4/l10qzmQ9Ops" height="1" width="1"/> An important observational study published in JAMA tracked over 34 000 women for more than 15 years and showed that cardiovascular mortality was significantly higher for women who developed atrial fibrillation as an incident event. More than ever, it is essential to find the etiology of atrial fibrillation in women and aggressively treat all underlying factors.

See also:

Conen D, Chae CU, Glynn RJ, et al. Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. JAMA 2011; 305:2080-2087. Available here.

]]> Thu, 25 Aug 2011 10:45:00 -0400 http://feedproxy.google.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~3/l10qzmQ9Ops/women-with-atrial-fibrillation-focus-on-etiology-and-treatment http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2011/8/25/women-with-atrial-fibrillation-focus-on-etiology-and-treatment http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2011/8/25/women-with-atrial-fibrillation-focus-on-etiology-and-treatment#comments Heart failure and transplantation with Dr Ileana Piña http://blogs.theheart.org/images/thumbnails/women-with-atrial-fibrillation-focus-on-etiology-and-treatment.jpg 0 http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2011/8/25/women-with-atrial-fibrillation-focus-on-etiology-and-treatment CRT and ICD implantation in difficult times Heart failure and transplantation with Dr Ileana Piña info@theheart.org An examination of the data from controversial recent studies into appropriateness of ICD implantation and cardiac resynchronization therapy underlines the importance of following the guidelines to ensure optimum patient care.<img src="http://feeds.feedburner.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~4/CObcxiMLtks" height="1" width="1"/> An examination of the data from controversial recent studies into appropriateness of ICD implantation and cardiac resynchronization therapy underlines the importance of following the guidelines to ensure optimum patient care.

See:

Al-Khatib SM, Hellkamp A, Curtis J, et al. Non-evidence-based ICD implantations in the United States. JAMA 2011; 305:43-49. Available here.

Controversial ICD-appropriateness study questioned in JAMA letters

Sipahi I, Carrigan TP, Rowland DY, et al. Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy. Meta-analysis of randomized controlled trials. Arch Intern Med 2011; DOI:10.1001/archinternmed.2011.247. Available here.

CRT: No clinical benefit seen in "moderately" prolonged QRS; many getting it needlessly

]]> Wed, 22 Jun 2011 11:30:00 -0400 http://feedproxy.google.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~3/CObcxiMLtks/crt-and-icd-implantation-in-difficult-times-following-the-guidelines-providing-evidence http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2011/6/22/crt-and-icd-implantation-in-difficult-times-following-the-guidelines-providing-evidence http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2011/6/22/crt-and-icd-implantation-in-difficult-times-following-the-guidelines-providing-evidence#comments Heart failure and transplantation with Dr Ileana Piña http://blogs.theheart.org/images/thumbnails/crt-and-icd-implantation-in-difficult-times-following-the-guidelines-providing-evidence.jpg 1 http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2011/6/22/crt-and-icd-implantation-in-difficult-times-following-the-guidelines-providing-evidence Optimal medical therapy holds its own in STICH Heart failure and transplantation with Dr Ileana Piña info@theheart.org Optimal medical therapy holds its own in STICH. An examination of the "crossover patients" in STICH shows that optimal medical therapy must never be overlooked.<img src="http://feeds.feedburner.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~4/V1ZLyHyORNU" height="1" width="1"/> An examination of the "crossover patients" in STICH shows that optimal medical therapy must never be overlooked.

See:

STICH: Focusing on the "crossover" patients

STICH substudy: Viability testing didn't affect treatment outcomes

Docs say STICH "hypothesis one" supports CABG in HF patients despite missing primary end point

Surgical Treatment for Ischemic Heart Failure Trial with Dr Robert Bonow

PARTNER, EVEREST II, STICH and all that jazz from ACC 2011 with Valentin Fuster

]]> Thu, 26 May 2011 14:50:00 -0400 http://feedproxy.google.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~3/V1ZLyHyORNU/optimal-medical-therapy-holds-its-own-in-stich http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2011/5/26/optimal-medical-therapy-holds-its-own-in-stich http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2011/5/26/optimal-medical-therapy-holds-its-own-in-stich#comments Heart failure and transplantation with Dr Ileana Piña http://blogs.theheart.org/images/thumbnails/optimal-medical-therapy-holds-its-own-in-stich.jpg 0 ACC 2010 ACC 2010 http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2011/5/26/optimal-medical-therapy-holds-its-own-in-stich STICH: Focusing on the "crossover" patients Heart failure and transplantation with Dr Ileana Piña info@theheart.org STICH: Focusing on the "crossover" patients. What can we learn from the patients in the STICH trial who crossed over from their original line of therapy (from bypass plus medical therapy to medical therapy alone, and vice versa)?<img src="http://feeds.feedburner.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~4/FSOk9nM-HHk" height="1" width="1"/> What can we learn from the patients in the STICH trial who crossed over from their original line of therapy (from bypass plus medical therapy to medical therapy alone, and vice versa)?

See:

STICH substudy: Viability testing didn't affect treatment outcomes

Docs say STICH "hypothesis one" supports CABG in HF patients despite missing primary end point

PARTNER, EVEREST II, STICH and all that jazz from ACC 2011 with Valentin Fuster

STICH, EVEREST, RIVAL, and top interventional trials from ACC 2011

]]> Fri, 08 Apr 2011 12:30:00 -0400 http://feedproxy.google.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~3/FSOk9nM-HHk/stich-focusing-on-the-crossover-patients http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2011/4/8/stich-focusing-on-the-crossover-patients http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2011/4/8/stich-focusing-on-the-crossover-patients#comments Heart failure and transplantation with Dr Ileana Piña http://blogs.theheart.org/images/thumbnails/stich-focusing-on-the-crossover-patients.jpg 0 acc 2011 acc 2011 http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2011/4/8/stich-focusing-on-the-crossover-patients Updating the AHA's guidelines for prevention of cardiovascular disease in women Heart failure and transplantation with Dr Ileana Piña info@theheart.org The recent update to the AHA's effectiveness-based guidelines for prevention of heart disease in women is notable for its refined focus on several issues, including a revised definition of risk, risk during pregnancy, BP control, and understanding diversi<img src="http://feeds.feedburner.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~4/x_NcD7VgoLY" height="1" width="1"/> The recent update to the AHA's effectiveness-based guidelines for prevention of heart disease in women is notable for its refined focus on several issues, including a revised definition of risk, risk during pregnancy, blood-pressure control, and understanding population diversity to promote prevention.

See:

Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of CVD in women—2011 update. A guideline from the American Heart Association. Circulation 2011; DOI:10.1161/CIR.0b013e31820faaf8. Available here.

Threshold for "high risk" reduced in new AHA guidance on CVD prevention for women

Believing the symptoms: Bettering the outcomes of women with heart disease

ESC call to action on substandard CV care in women

]]> Wed, 16 Mar 2011 09:40:00 -0400 http://feedproxy.google.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~3/x_NcD7VgoLY/updating-the-aha-s-guidelines-for-prevention-of-cardiovascular-disease-in-women-3 http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2011/3/15/updating-the-aha-s-guidelines-for-prevention-of-cardiovascular-disease-in-women-3 http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2011/3/15/updating-the-aha-s-guidelines-for-prevention-of-cardiovascular-disease-in-women-3#comments Heart failure and transplantation with Dr Ileana Piña http://blogs.theheart.org/images/thumbnails/updating-the-aha-s-guidelines-for-prevention-of-cardiovascular-disease-in-women-3.jpg 0 http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2011/3/15/updating-the-aha-s-guidelines-for-prevention-of-cardiovascular-disease-in-women-3 Electronic health records: Bettering uptake and use Heart failure and transplantation with Dr Ileana Piña info@theheart.org Despite President Obama's deadline of 2014 for hospitals and practices to adopt electronic health records, uptake has been slow. In our digital age, we will all gain from dropping outdated record practices and adopting electronic records.<img src="http://feeds.feedburner.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~4/y7ym_0ZLrMY" height="1" width="1"/> Despite President Obama's deadline of 2014 for hospitals and practices to adopt electronic health records, uptake has been slow. In our digital age, we will all gain from dropping outdated record practices and adopting electronic records.

See:

Jha AK. Meaningful use of electronic health records: The road ahead. JAMA 2010;304(15):1709-1710. Abstract.

When an EMR feels like a computer without internet how do we share health records?

Electronic medical record adoption: The worst year of my professional life!

]]> Mon, 29 Nov 2010 12:15:00 -0500 http://feedproxy.google.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~3/y7ym_0ZLrMY/electronic-health-records-bettering-uptake-and-use http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2010/11/29/electronic-health-records-bettering-uptake-and-use http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2010/11/29/electronic-health-records-bettering-uptake-and-use#comments Heart failure and transplantation with Dr Ileana Piña http://blogs.theheart.org/images/thumbnails/electronic-health-records-bettering-uptake-and-use.jpg 0 AHA 2010 AHA 2010 http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2010/11/29/electronic-health-records-bettering-uptake-and-use Petitioning the Social Security Administration for compassionate disability for HF, transplant, and congenital heart-disease patients Heart failure and transplantation with Dr Ileana Piña info@theheart.org The lag between recognition of disability status and receipt of Medicare is 24 months—a long period rife with events for the most seriously ill patients, with costly and tragic consequences. Learn more.<img src="http://feeds.feedburner.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~4/3POPX7in4Cw" height="1" width="1"/> The lag between recognition of disability status and receipt of Medicare is 24 months—a long period rife with events for the most seriously ill patients, with costly and tragic consequences. Learn more. 

]]> Tue, 16 Nov 2010 15:30:00 -0500 http://feedproxy.google.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~3/3POPX7in4Cw/petitioning-the-social-security-administration-for-compassionate-disability-for-hf-transplant-and-congenital-heartdisease-patients-3 http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2010/11/16/petitioning-the-social-security-administration-for-compassionate-disability-for-hf-transplant-and-congenital-heartdisease-patients-3 http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2010/11/16/petitioning-the-social-security-administration-for-compassionate-disability-for-hf-transplant-and-congenital-heartdisease-patients-3#comments Heart failure and transplantation with Dr Ileana Piña http://blogs.theheart.org/images/thumbnails/petitioning-the-social-security-administration-for-compassionate-disability-for-hf-transplant-and-congenital-heartdisease-patients-3.jpg 0 AHA 2010 AHA 2010 http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2010/11/16/petitioning-the-social-security-administration-for-compassionate-disability-for-hf-transplant-and-congenital-heartdisease-patients-3 Heart-failure trials to look for at AHA 2010 Heart failure and transplantation with Dr Ileana Piña info@theheart.org Watch out for the following top trials in heart failure at the AHA Scientific Sessions 2010<img src="http://feeds.feedburner.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~4/caILxgCVYAQ" height="1" width="1"/>

1.      Benefits of Natriuretic Peptide Guided Heart Failure Therapy for Patients With Chronic Left Ventricular Systolic Dysfunction: Primary Results of the Pro-BNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study, presented by Dr Jim Januzzi on Monday, November 15, 2010 at 9:45 AM

2.      Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF), presented by Dr Adrian Hernandez on Sunday, November 14 at 4:51PM

3.      The Effect of Eplerenone versus Placebo on Cardiovascular Mortality or Heart Failure Hospitalization in Subjects with NYHA Class II Chronic Systolic Heart Failure (EMPHASIS-HF), presented by Dr Faiez Zannad on Sunday, November 14 at 4:29 PM

See:

Late-breaking clinical trials at AHA 2010

What's going to be hot at AHA 2010

]]> Wed, 10 Nov 2010 16:35:00 -0500 http://feedproxy.google.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~3/caILxgCVYAQ/heartfailure-trials-to-look-for-at-aha-2010-2 http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2010/11/10/heartfailure-trials-to-look-for-at-aha-2010-2 http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2010/11/10/heartfailure-trials-to-look-for-at-aha-2010-2#comments Heart failure and transplantation with Dr Ileana Piña http://blogs.theheart.org/images/thumbnails/heartfailure-trials-to-look-for-at-aha-2010-2.jpg 2 AHA 2010 AHA 2010 http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2010/11/10/heartfailure-trials-to-look-for-at-aha-2010-2 Collaborative care in heart-failure patients Heart failure and transplantation with Dr Ileana Piña info@theheart.org How does patient adherence—to both medications and physician recommendations—work? In her recent study, Dr Lynda Powell sought to understand the potential role of "collaborative care" in improving adherence and outcomes.<img src="http://feeds.feedburner.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~4/JyYQzgSq2C4" height="1" width="1"/> How does patient adherence—to both medications and physician recommendations—work? In her recent study, Dr Lynda Powell (Rush University Medical Center, Chicago, IL) sought to understand the potential role of "collaborative care" in improving adherence and outcomes.

See:

Powell LH, Calvin JE Jr, Richardson D, et al. Self-management counseling in patients with heart failure: the heart failure adherence and retention randomized behavioral trial. JAMA 2010; 304:1331-1338. Abstract.

Self-management counseling a bust in HF

]]> Wed, 20 Oct 2010 15:25:00 -0400 http://feedproxy.google.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~3/JyYQzgSq2C4/collaborative-care-in-heartfailure-patients2 http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2010/11/11/collaborative-care-in-heartfailure-patients2 http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2010/11/11/collaborative-care-in-heartfailure-patients2#comments Heart failure and transplantation with Dr Ileana Piña http://blogs.theheart.org/images/thumbnails/collaborative-care-in-heartfailure-patients2.jpg 0 http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2010/11/11/collaborative-care-in-heartfailure-patients2 Focus on exercise in older men and in women at ESC 2010 Heart failure and transplantation with Dr Ileana Piña info@theheart.org Two understudied groups were the focus of papers presented in Stockholm that underline our incomplete understanding of biomarkers and of left ventricular hypertrophy in female athletes.<img src="http://feeds.feedburner.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~4/a24XwYfabk4" height="1" width="1"/> Two understudied groups were the focus of papers presented in Stockholm that underline our incomplete understanding of biomarkers and of left ventricular hypertrophy in female athletes.

See:

Exercise can treat cardiovascular disease as well as prevent it

]]> Wed, 01 Sep 2010 08:30:00 -0400 http://feedproxy.google.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~3/a24XwYfabk4/esc-2010-pina-blog http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2010/9/1/esc-2010-pina-blog http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2010/9/1/esc-2010-pina-blog#comments Heart failure and transplantation with Dr Ileana Piña http://blogs.theheart.org/images/thumbnails/esc-2010-pina-blog.jpg 1 ESC 2010 ESC 2010 http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2010/9/1/esc-2010-pina-blog ARBs and lung-cancer risk in a new meta-analysis by Dr Ike Sipahi Heart failure and transplantation with Dr Ileana Piña info@theheart.org <p>In his recent <a href="http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045%2810%2970106-6/abstract">meta-analysis</a>, Dr Ike Sipahi found that the use of angiotensin-receptor blockers (ARBs) increased the risk of developing lung cancer by 25%. Drs Pi&ntilde;a and Sipahi discuss the implications of the research and whether the evidence is strong enough for concern.</p> <p>Are you concerned by a possible link between ARBs and cancer? </p> <p>See:</p> <p><a href="http://www.theheart.org/article/1087349.do" title="Angiotensin-receptor blockers have been associated with a modest increased risk of developing cancer in a new meta-analysis. Specifically, there was a significant 25% increased risk of lung cancer with these agents. The results, while concerning, must be ">Modest lung-cancer signal with angiotensin-receptor blockers </a></p> <p>Sipahi I, Debanne SM, Rowland DY, et al. Angiotensin-receptor blockade and risk of cancer: Meta-analysis of randomised controlled trials. <em>Lancet Oncol</em> 2010; DOI:10.1016/S1470-2045(10)70106-6. <a href="http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045%2810%2970106-6/abstract">Abstract</a>.</p><img src="http://feeds.feedburner.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~4/pwmu28iAMI8" height="1" width="1"/> In his recent meta-analysis, Dr Ike Sipahi found that the use of angiotensin-receptor blockers (ARBs) increased the risk of developing lung cancer by 25%. Drs Piña and Sipahi discuss the implications of the research and whether the evidence is strong enough for concern.

Are you concerned by a possible link between ARBs and cancer?

See:

Modest lung-cancer signal with angiotensin-receptor blockers

Sipahi I, Debanne SM, Rowland DY, et al. Angiotensin-receptor blockade and risk of cancer: Meta-analysis of randomised controlled trials. Lancet Oncol 2010; DOI:10.1016/S1470-2045(10)70106-6. Abstract.

]]> In his recent meta-analysis, Dr Ike Sipahi found that the use of angiotensin-receptor blockers (ARBs) increased the risk of developing lung cancer by 25%. Drs Piña and Sipahi discuss the implications of the research and whether the evidence is strong enough for concern.

Are you concerned by a possible link between ARBs and cancer?

See:

Modest lung-cancer signal with angiotensin-receptor blockers

Sipahi I, Debanne SM, Rowland DY, et al. Angiotensin-receptor blockade and risk of cancer: Meta-analysis of randomised controlled trials. Lancet Oncol 2010; DOI:10.1016/S1470-2045(10)70106-6. Abstract.

]]> Thu, 19 Aug 2010 15:50:00 -0400 http://feedproxy.google.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~3/pwmu28iAMI8/arbs-and-lungcancer-risk-in-a-new-metaanalysis-by-dr-ike-sipahi-2 http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2010/8/19/arbs-and-lungcancer-risk-in-a-new-metaanalysis-by-dr-ike-sipahi-2 http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2010/8/19/arbs-and-lungcancer-risk-in-a-new-metaanalysis-by-dr-ike-sipahi-2#comments Heart failure and transplantation with Dr Ileana Piña http://blogs.theheart.org/images/thumbnails/arbs-and-lungcancer-risk-in-a-new-metaanalysis-by-dr-ike-sipahi-2.jpg 0 http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2010/8/19/arbs-and-lungcancer-risk-in-a-new-metaanalysis-by-dr-ike-sipahi-2 Help bring HF hospital readmission rates down by joining the H2H Initiative Heart failure and transplantation with Dr Ileana Piña info@theheart.org <p><span>More than half of heart-failure patients are not seen for follow-up by their caregivers within 30 days of discharge from the hospital. We know that hospital readmission has an alarmingly negative impact on mortality rates, so it's time to do more to fix this problem. Find out how you can join the </span>H2H Initiative and help to lower hospital readmission rates in HF. </p> <p>See:</p> <p><a href="http://h2hquality.org/" target="_blank">H2H: Hospital-to-Home</a> </p> <p><span>Hernandez AF, Greiner MA, Fonarow GC, et al. JAMA. </span>Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. 2010 May 5;303(17):1716-22. <a href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;TransSchema=title&amp;term=Relationship%20between%20early%20physician%20follow-up%20and%2030-day%20readmission%20among%20Medicare%20beneficiaries%20hospitalized%20for%20heart%20failur">Abstract</a>.</p> <p><span><a href="http://radio.theheart.org/fellows-corner-radio/2010/7/7/episode-18-improving-outcomes-for-patients-with-acute-hf-with-drs-adrian">Episode #18: Improving outcomes for patients with acute HF with Drs Adrian Hernandez and Robb Kociol</a></span> </p> <p><a href="http://www.theheart.org/article/1075065.do" title="One potential way hospitals can cut their 30-day rehospitalization rates after a heart-failure hospitalization: make sure the patient has a follow-up visit to the physician within a week of discharge, an analysis confirms. ">Don't come back soon: Early follow-up after HF discharge shows early benefit </a></p><img src="http://feeds.feedburner.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~4/ErljEIWgO0A" height="1" width="1"/> More than half of heart-failure patients are not seen for follow-up by their caregivers within 30 days of discharge from the hospital. We know that hospital readmission has an alarmingly negative impact on mortality rates, so it's time to do more to fix this problem. Find out how you can join the H2H Initiative and help to lower hospital readmission rates in HF.

See:

H2H: Hospital-to-Home

Hernandez AF, Greiner MA, Fonarow GC, et al. JAMA. Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. 2010 May 5;303(17):1716-22. Abstract.

Episode #18: Improving outcomes for patients with acute HF with Drs Adrian Hernandez and Robb Kociol

Don't come back soon: Early follow-up after HF discharge shows early benefit

]]> More than half of heart-failure patients are not seen for follow-up by their caregivers within 30 days of discharge from the hospital. We know that hospital readmission has an alarmingly negative impact on mortality rates, so it's time to do more to fix this problem. Find out how you can join the H2H Initiative and help to lower hospital readmission rates in HF.

See:

H2H: Hospital-to-Home

Hernandez AF, Greiner MA, Fonarow GC, et al. JAMA. Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. 2010 May 5;303(17):1716-22. Abstract.

Episode #18: Improving outcomes for patients with acute HF with Drs Adrian Hernandez and Robb Kociol

Don't come back soon: Early follow-up after HF discharge shows early benefit

]]> Fri, 28 May 2010 13:20:00 -0400 http://feedproxy.google.com/~r/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/~3/ErljEIWgO0A/help-bring-hf-hospital-readmission-rates-down-by-joining-the-h2h-initiative-2 http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2010/7/16/help-bring-hf-hospital-readmission-rates-down-by-joining-the-h2h-initiative-2 http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2010/7/16/help-bring-hf-hospital-readmission-rates-down-by-joining-the-h2h-initiative-2#comments Heart failure and transplantation with Dr Ileana Piña http://blogs.theheart.org/images/thumbnails/help-bring-hf-hospital-readmission-rates-down-by-joining-the-h2h-initiative-2.jpg 0 http://blogs.theheart.org/Heart-failure-and-transplantation-with-Dr-Ileana-Pina/2010/7/16/help-bring-hf-hospital-readmission-rates-down-by-joining-the-h2h-initiative-2